Search Results

Business

Eargo Reports Second Quarter 2023 Financial Results

Eargo, Inc., a medical device company on a mission to improve hearing health, reported its financial results for the second quarter ended June 30, 2023.

August 10, 2023

·

18 min read

Biotech Bay

Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency is Cured

Eargo, Inc., a medical device company on a mission to improve the quality of life of people with hearing loss, announced that it received a letter from The Nasdaq Stock Market LLC dated February 1, 2023 informing Eargo that the Company’s minimum bid price deficiency has been cured.

February 6, 2023

·

1 min read

Business

Eargo Reports Fourth Quarter 2022 Financial Results

Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, today reported its financial results for the fourth quarter ended December 31, 2022.

March 23, 2023

·

16 min read

Business

Eargo Reports First Quarter 2023 Financial Results

Eargo, Inc., a medical device company on a mission to improve hearing health, reported its financial results for the first quarter ended March 31, 2023.

May 11, 2023

·

16 min read

Business

Eargo to Report First Quarter 2023 Financial Results on May 11, 2023

Eargo, Inc. today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023.

May 4, 2023

·

1 min read

Business

Eargo and NationsBenefits Announce Strategic Partnership

Eargo, Inc., a medical device company on a mission to improve the quality of life for people with hearing loss, and NationsBenefits, hearing aids starting on January 1, 2023.

December 12, 2022

·

4 min read

Business

Eargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter 2022 after market close on March 23, 2023.

March 17, 2023

·

1 min read

Business

Eargo Announces Issuance of Quarterly Report for Third Fiscal Quarter 2022

Eargo, Inc., a medical device company on a mission to improve the quality of life for people with hearing loss, announced the filing of Eargo’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022.

November 7, 2022

·

7 min read

Deals

Eargo to Complete a 1-for-20 Reverse Stock Split

Eargo, Inc. today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock.

January 11, 2023

·

4 min read

Biotech Bay

Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes Into Shares of Eargo Common Stock

Eargo, Inc., a medical device company on a mission to improve the quality of life for people with hearing loss, announced the closing and final results of its rights offering, which expired at 5:00 p.m. New York City time, on November 17, 2022.

November 29, 2022

·

3 min read